Eosinophil eotaxin receptor
US6271347A · kind A · utility
2Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 1997 |
| Grant date | Aug 7, 2001 |
| Priority date | — |
| Expiry date | Apr 24, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/715
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The eosinophil eotaxin receptor has been isolated, cloned and sequenced. This receptor is a human .beta.-chemokine receptor and has been designated "CC CKR3". The eosinophil eotaxin receptor may be used to screen and identify compounds that bind to the eosinophil eotaxin receptor. Such compounds would be useful in the treatment and prevention of atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and particularly bronchial asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.